Intermountain Health
Based in UT
🤖
AI Overview
With $1.3M in lobbying spend across 30 quarterly filings, Intermountain Health is a significant lobbying presence.
$1.3M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
3
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $170K |
| 2019 | $160K |
| 2020 | $140K |
| 2021 | $160K |
| 2022 | $140K |
| 2023 | $180K |
| 2024 | $170K |
| 2025 | $220K |
Lobbying Firms
MCDERMOTT WILL & SCHULTE LLP
What They Lobby For
- Issues relating to accurately identifying patients to their records.
- Issues affecting integrated health care delivery systems including health care reform implementation and health information technology legislation and regulation.
- Issues relating to helping Medicare and Medicaid beneficiaries live their healthiest lives possible; issues relating to Medicare Advantage; issues relating to operational efficiencies of plans, including timing for Medicaid rate approvals.
- Issues affecting integrated health care delivery systems including movement to value-based payment and health information technology legislation and regulation.
- Issues affecting integrated health care delivery systems including movement to value-based payment and health information technology legislation and regulation, and including advancing interoperability.
- Issues affecting integrated health care delivery systems including movement to value-based payment and health information technology legislation and regulations, including efforts to accurately identify patients to their data and efforts to advance interoperability.
- Issues affecting integrated health care delivery systems including movement to value-based payment; health information technology legislation and regulation, including efforts to accurately identify patients to their data and efforts to advance interoperability; and efforts to address the health impacts of the coronavirus.
- Issues relating to helping Medicare and Medicaid beneficiaries live their healthiest lives possible, including issues relating to Medicare Advantage; issues relating to operational efficiencies of plans, including timing for Medicaid rate approvals; issues relating to accurately identifying patients to their data; and issues relating to the health impacts of the coronavirus.
- Issues relating to helping Medicare and Medicaid beneficiaries live their healthiest lives possible, including issues relating to Medicare Advantage; issues relating to accurately identifying patients to their data; and issues relating to the health impacts of the coronavirus.
- Remove Section 510 that prohibits the promulgation or adoption of a unique patient health identifier so that patients can consistently and accurately be connecting to their health information.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.